COMMUNIQUÉS West-GlobeNewswire

Interpace Diagnostics Announces Additional Coverage of Thyroid Tests

08/03/2018 - 14:00

PARSIPPANY, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG ) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically [...]

Aeglea BioTherapeutics Doses First Uveal and Cutaneous Melanoma Patients in Phase 1 Cohort Expansions with Pegzilarginase

08/03/2018 - 14:00

AUSTIN, Texas, March 08, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with [...]

Selecta Biosciences to Report Fourth Quarter and Year End 2017 Financial Results on Thursday, March 15, 2018

08/03/2018 - 14:00

WATERTOWN, Mass., March 08, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB ), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by avoiding [...]

Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2017 Financial Results and Business Update

08/03/2018 - 13:45

Company Preparing for Potential Commercial Launch of AZEDRA® (iobenguane I 131) Ahead of U.S. Food and Drug Administration (FDA) April 30th Action Date Enrollment Complete in Phase 3 Trial for PSMA-Targeted SPECT/CT [...]

Innate Pharma Hosts R&D Day Today in London

08/03/2018 - 13:31

Innate Pharma Hosts R&D Day Today in London Innate Pharma presents a clinical update on its broad and diverse development portfolio of first- or best-in-class antibodies in immuno-oncology Update on the development [...]

Présentation R&D d'Innate Pharma ce jour à Londres

08/03/2018 - 13:31

Présentation R&D d'Innate Pharma ce jour à Londres Innate Pharma présente les avancées cliniques de son portefeuille d'anticorps innovants et diversifié en immuno-oncologie Mise à jour du programme de développement [...]

Marinus Pharmaceuticals to Present at the Barclays Global Healthcare Conference

08/03/2018 - 13:30

RADNOR, Pa., March 08, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS ), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric [...]

Neos Therapeutics to Host Fourth Quarter and Year-End 2017 Financial Results Conference Call on March 15, 2017

08/03/2018 - 13:30

DALLAS and FORT WORTH, Texas, March 08, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ: NEOS ), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR [...]

Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Results

08/03/2018 - 13:30

DUBLIN, Ireland, March 08, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL ), "Avadel" or "the Company," today announced its financial results for the fourth quarter and full year 2017. Highlights [...]

TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2017 Financial Results and Business Update

08/03/2018 - 13:30

NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX ) today announced its financial results for the fourth quarter and year ended December 31, 2017 and provided recent company developments [...]

Stemline Therapeutics to Present at Upcoming Investor Conferences

08/03/2018 - 13:30

NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, announced today that [...]

Ossur Hf : New share option program

08/03/2018 - 13:05

Announcement no. 19/2018 Reykjavik, 8 March 2018 New share option program Enclosed information on a new share option program for the CEO and other members of the Executive Management, their direct reports (with [...]

Ossur Hf : Board decisions following the Annual General Meeting

08/03/2018 - 13:03

Announcement no. 18/2018 Reykjavik, 8 March 2018 Board decisions following the Annual General Meeting Enclosed are the Board decisions following the Annual General Meeting of Össur hf. held today, Thursday 8 March 2018 [...]

Aptose To Release Fourth Quarter and Year End December 31, 2017 Financial Results and Hold Conference Call on March 27, 2018

08/03/2018 - 13:00

SAN DIEGO and TORONTO, March 08, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO ) (TSX: APS ), a clinical-stage biotechnology company developing first-in-class agents that target the dysregulated [...]

Melinta Therapeutics Partner, Menarini Group, Submits Marketing Authorization Application for Delafloxacin in Europe

08/03/2018 - 13:00

NEW HAVEN, Conn., March 08, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, today [...]

Onconova Therapeutics, Inc. Reports Business Highlights and Full Year 2017 Financial Results

08/03/2018 - 13:00

NEWTOWN, Pa., March 08, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat [...]

Ossur Hf : Results of the Annual General Meeting

08/03/2018 - 11:01

Announcement no. 17/2018 Reykjavik, 8 March 2018 Results of the Annual General Meeting Enclosed are the results of the Annual General Meeting of Össur hf. held today, Thursday 8 March 2018. The Icelandic Register of [...]

Affimed to Present at the Cowen and Company 38th Annual Health Care Conference

08/03/2018 - 11:00

Heidelberg, Germany, March 8, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Adi [...]

ViaDerma, Inc. Provides an Update of Current Marketing Activities

08/03/2018 - 11:00

LOS ANGELES, March 08, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink:VDRM), is pleased to provide an update of the Company’s current marketing activities: ViaDerma is in discussions with a Huntington Beach based [...]